



Emergency Oral Contraceptive Consultations in
Pharmacies in a Rural Setting: An Epidemiological
Analysis




Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Pearce, E & Jolly, K 2020, 'Emergency Oral Contraceptive Consultations in Pharmacies in a Rural Setting: An
Epidemiological Analysis', Journal of Pharmacy Practice. https://doi.org/10.1177/0897190020961698
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 11. May. 2021
Research Article
Emergency Oral Contraceptive Consultations
in Pharmacies in a Rural Setting: An
Epidemiological Analysis
Emma Pearce, MPH1 , and Kate Jolly, PhD1
Abstract
Background: Emergency contraception has been available in pharmacies across England since 2001.There is a paucity of evi-
dence describing those women accessing the service, particularly in rural locations, where pharmacies are integral to improving
healthcare accessibility. Methods: Routinely collected data from all pharmacy consultations for emergency contraception in
Shropshire, England, were obtained and anonymized for the study period April 1, 2016 to January 31, 2019. Consultations were
described by time, age of consultee, rationale for consultation, method dispensed (levonorgestrel or ulipristal acetate), referral for
copper intrauterine device fitting, chlamydia screening where appropriate and reason for choosing pharmacy setting. Repeat
attenders were also described separately. Results: 3499 consultations occurred during the study period; 39% were aged between
16-20 years, and 52% attended following unprotected sexual intercourse. Levonorgestrel was initially most prescribed, however
ulipristal acetate overtook it in 2018. Onward referral for copper intrauterine device and age-appropriate chlamydia screening
took place in 3% and 4% of the eligible populations respectively. Women overwhelmingly chose the pharmacy setting owing to its
convenience. Repeat attenders tended to be younger than single attenders, but otherwise similar. Conclusion: Pharmacy-based
emergency contraception is an important and well-utilized service in this rural location and continued funding and possible service
expansion should be considered.
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Background
Women in England have been accessing over-the-counter oral
emergency contraception in pharmacy settings since 2001,
increasing their opportunities to take positive steps toward
improved reproductive health.1 Two types of oral emergency
contraception are available in these pharmacies: levonorgestrel
and ulipristal acetate. Ulipristal acetate may be taken up to 120
hours following contraceptive failure or unprotected sexual
intercourse, whereas levonorgestrel must be taken within 72
hours.2,3 Although the most effective method of emergency
contraception is insertion of the copper intrauterine device
within 120 hours, this requires specialist assessment and skills
in a general practice or sexual health setting and cannot be
provided in pharmacies.4,5 Despite many years of availability,
few studies have examined the characteristics of women acces-
sing oral emergency contraception from pharmacies, particu-
larly those in more rural locations.1,6
Women living in rural English counties often face specific
reproductive health challenges related to service accessibility.
Sexual and reproductive health clinics are less likely to be
located near to home, and often have shorter opening hours and
fewer staff than higher footfall, inner-city clinics. Rural English
counties, in comparison to more urban areas, also have poorer
access to general practice services, although maintain adequate
access to community pharmacies; this effect is independent of
levels of social deprivation.7,8 Transport links within and
between rural areas are often fragmented, and car ownership can
be variable, with young people in particular experiencing prob-
lems accessing services not located near major public transport
hubs or schools.9 Assurance of confidential service provision
also ranks higher for young people accessing sexual and repro-
ductive health services in rural locations compared to their urban
counterparts.10 The above considerations impact not only upon
the provision of emergency contraception, but also on access to
reliable ongoing contraceptive methods, alongside the broader
range of sexual and reproductive healthcare.11,12
Current public health challenges, both monetary and service
pressures, are negatively impacting the provision of services
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such as emergency contraception access in a variety of loca-
tions across England.13 In rural counties, where extra chal-
lenges are placed in the way of accessing sexual and
reproductive healthcare, it is important to understand how ser-
vices are utilized and by whom, to make a case for retention
and improvement of services. Pharmacies are a key location to
study as they may provide an alternative route of delivering
safe, effective healthcare in rural communities.
The objective of this study is to describe all individuals
requesting emergency contraception consultations in pharma-
cies within Shropshire Local Authority boundaries during the
period April 1, 2016 to January 31, 2019.
Study Method
Data Source
This study utilizes routinely collected PharmOutcomes data
from April 1, 2016 to January 31, 2019.14 All emergency con-
traception consultations recorded on the database during this
timeframe were included in the study. Any pharmacy with a
pharmacist qualified to provide emergency contraception and
under contract with the Local Authority may provide emer-
gency contraception, without charge, to any person who
requests it and fits the clinical criteria. PharmOutcomes data
must be provided to the Local Authority to ensure adequate
reimbursement for the service; data are entered manually by the
pharmacist based on self-report of the client at the time of the
consultation and reviewed by the Local Authority on a quar-
terly basis. All fields in the database, excluding free text boxes
for further comment and ethnicity of attendee, are mandatory,
ensuring receipt of a complete dataset.
Data were accessed in March 2019 by a Shropshire Local
Authority data analyst, anonymized by the study author, and
stored securely.
Variables
Time: Consultations are described by financial quarter of atten-
dance, beginning from Quarter Two of 2016 (April to June). As
data for the final quarter (Quarter One of 2019) are incomplete,
owing to timing of data extraction, all consultations from this
period are combined with Quarter Four of 2018, extending this
quarter from October 2018 to January 2019.
Age: Age at consultation is displayed in five-year age bands;
a separate 2-year category (13-15 years) separates those below
the age of consent and therefore subject to Fraser competence
assessment as part of the consultation. Subjects were excluded
from analyses by age if recorded age was  12 years or  60
years, the assumption being that this data point was incorrect.
For ease of display, smaller age categories were combined
when data were displayed graphically; original results for indi-
vidual categories can obtained on reasonable request from the
corresponding author.
Consultation rationale: Four categories were recorded:
unprotected sexual intercourse, condom failure, failure of reg-
ular hormonal contraceptive method (combined or
progesterone-only pill) or vomiting following emergency con-
traception usage within 3 hours.
Type of emergency contraception prescribed: Recorded data
detailed type of emergency contraception dispensed (levonor-
gestrel or ulipristal acetate), dosage, clinical comments (free
text box) and reasons for not dispensing (free text box).
Onward referral for copper intrauterine device: This field is
recorded as “accepted” or “declined.” If accepted, a woman is
given contact details of the nearest service provider for copper
intrauterine device fitting, and is also offered oral emergency
contraception, if clinically appropriate, to provide cover in case
of a delay in accessing the service.
National Chlamydia Screening Programme: In England,
everyone aged 15 to 24 years should be offered a free chlamy-
dia screening test in a pharmacy setting if attending for emer-
gency contraception or condom purchase/distribution as part of
the National Chlamydia Screening Programme.15 Data can be
entered as “provided,” “not provided” or “age inappropriate.”
Owing to the distribution of available data and predetermined
age ranges, chlamydia screening is examined in those aged
13-25 years in this study.
Reason for choosing pharmacy setting: Following consulta-
tion, women are asked to provide a reason for choosing the
pharmacy setting, rather than other locations or online services,
for provision of emergency contraception. Six categories were
created within the database by the study author: Advice from
healthcare professional, advice from friends/family, conveni-
ence, advertising, assurance of confidentiality or “other”.
Data Analysis
Data are displayed graphically and described using percen-
tages. All subjects had a unique anonymized patient number,
allowing any consultation linked to a repeat attender to be
highlighted and analyzed independently. Repeat and single
attendees are compared using the Chi Squared test, with statis-
tical significance set at the 5% level. All analyses were under-
taken using Microsoft Excel (Office 365 Version).
Ethical Approval and Patient and Public Involvement
Ethical approval was obtained from the University of Birming-
ham (ERN_19-0342). Data is also covered under the Shrop-
shire Local Authority GDPR statement, and written permission
to analyze and publish the data was obtained from the Caldicott
Guardian in Shropshire Local Authority in February 2019.
This study was designed and completed following stake-
holder feedback gathered for a local needs assessment, in
which the general public and service providers highlighted
anecdotal inequities in access to all forms of contraception
within Shropshire.
Results
Data were recorded on 3499 emergency contraception consul-
tations during the study period. 3099 individual women
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attended, and 321 women attended at least twice (721 con-
sultations); this equates to 10% of all individual women
accounting for 20.6% of consultations. Consultations per quar-
ter remained at 200-250 from Quarter 2, 2016 to Quarter 1,
2017. In 2017 consultations rose to 330 to 350 per quarter,
from Quarter 2, 2017 to Quarter 1, 2018 and then decreased
for the remainder of the study period, eventually returning to
baseline (Figure 1).
Just 2 attendees had recorded ages outside of 13 to 55 years.
Sixty-six (1.9%) consultations did not result in emergency con-
traception dispensing. Commonly identified reasons included
clinical suspicion of ectopic pregnancy, delayed presentation,
or incorrect presentation. Consultations were noted to be influ-
enced by age. Pharmacy services were most used by those aged
16-20 years, with 39% of all subjects belonging to this group.
Consultations decreased rapidly after the age of 20 (Figure 2).
Figure 1. Consultations for emergency contraception in Shropshire pharmacies per quarter, April 2016 to January 2019.
Figure 2. Consultations by age group and time period, April 2016 to January 2019.
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Of note, the number of consultations by those aged 13-15 years
was similar to the numbers aged 36-40 years and 41-45 years.
No significant difference was seen by age group over time. Just
over two-thirds (67%) of the total study population were aged
between 13-25 years. Of these, 4.7% received a chlamydia
screening test during the study period.
Slightly over half of consultations (52.6%) were for unpro-
tected sexual intercourse; 38.4% were for condom failure and
8.8% were for failure of regular hormonal methods. Just 2 con-
sultations (0.02%) were prompted by vomiting following a previ-
ous administration of emergency contraception earlier that same
day. These trends varied little when adjusted for age (Figure 3).
Across the whole study period, levonorgestrel was the more
commonly supplied emergency contraception method (78.5%
consultations). Ulipristal acetate supply remained stable
throughout 2016/17, at between 5-10% of supplied items and
then increased markedly from the beginning of 2018. From
April 2018 onward, ulipristal acetate was the more commonly
supplied emergency contraception method, dispensed in over
50% of consultations per quarter (Figure 4). The effect of age
on type of emergency contraception was minimal, with around
20% of total consultations resulting in ulipristal acetate supply;
this was lowest in those aged 51-55 years (10%) and highest in
those aged 36-40 years (26.1%).
Onward referral for copper intrauterine device fitting was
accepted in just 3% of all consultations during the study period.
Popularity was increased among those aged 31-35 years, with
4.2% of women accepting referral. No women aged 51-55
accepted onward referral for copper intrauterine device fitting.
Rates of copper intrauterine device referral remained stable over
the course of the study and followed a similar pattern to that of
consultation activity overall, with a referral low of 0.78% seen in
Quarter 2, 2016, and a high of 5.8% in Quarter 3, 2017. Of the
104 women referred for copper intrauterine device insertion,
91% also received emergency contraception at the time of con-
sultation. The remainder refused on the basis that they did not
wish to use any hormonal method of pregnancy prevention.
Convenience was the main reason for choosing the phar-
macy over other healthcare settings, as highlighted in 81.4%
of consultations. 7.3% of consultations resulted from a health-
care professional recommendation; this was commonly
ascribed to a lack of appointment capacity at a general prac-
tice/sexual health clinic, or because alternate pharmacies had
low stock or no qualified pharmacist on duty. 6.1% of consul-
tations followed recommendations from friends and family,
and the remainder of attendances were attributed to viewing
advertising for the service (1.1%), feeling reassured about the
confidentiality (2%) or other reasons, such as having used that
pharmacy before for healthcare reasons (2.1%).
Of the 3099 individual women accessing the pharmacy ser-
vice during the study period, 321 accessed it on 2 or more
occasions. The characteristics of these women are highlighted
below and compared to the characteristics of those women
attending for a single consultation during the study period
(Table 1). A significant difference is seen in the age profile
of consultations, with 36.7% aged 16-20 in the single attender
group compared to 59.5% in the repeat attender group (p <
0.0001). No significant differences were seen in consultations
for unprotected sexual intercourse, acceptance of copper
intrauterine device referral or chlamydia screening in the
appropriate age group.
Discussion
Consultations for emergency contraception were commonplace
in Shropshire pharmacies between April 2016 and January
Figure 3. Consultation rationale by age group, April 2016 to January 2019.
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2019, and although consultations rose sharply during 2017-18,
they returned to baseline by the end of the study period. Based
upon 2018 Office for National Statistics figures for women
aged 13-55 living within Shropshire Local Authority bound-
aries, the crude consultation rate for emergency contraception
in this study cohort can be calculated at 16 per 1000 women.16
Those aged 16-20 represent 39% of all consultations and 53%
of consultations across all age groups occurred following an
episode of unprotected sexual intercourse. A change in UK-
wide prescribing guidance part way through the study period
led to ulipristal acetate overtaking levonorgestrel as the most
dispensed method of emergency contraception.4 Chlamydia
screening (in line with the National Chlamydia Screening Pro-
gramme recommendations) and onward referral for copper
intrauterine device was low throughout. 321 women, 10% of
all those who consulted for emergency contraception, returned
at least twice during the study period. Aside from the age
profile, no significant differences between these groups were
seen.
This study is the first of its kind to examine patterns in
pharmacy-dispensed emergency contraception in a rural loca-
tion following the change in sexual health funding in England
from National Health Service to Local Authority control. This
is also one of the first studies to demonstrate the impact of a
national change in guidance on the dispensing patterns of uli-
pristal acetate and levonorgestrel in the pharmacy setting. It has
highlighted several important issues, including the high volume
of women accessing the service, including those who access it
multiple times over a relatively short period of time, poor
uptake of the most effective method of emergency contracep-
tion and extremely low rates of opportunistic chlamydia
screening. By utilizing PharmOutcomes, a large amount of
information on a specific population of women has been
collected and enables an in-depth examination of a vital com-
ponent of sexual health service provision that is likely to be
replicated in similar counties across England, and other similar
health services.
This study is somewhat limited by the data recording
method. Changes were made to the database by commissioners
in February 2018, meaning that some data, such as previous use
of emergency contraception from any provider, ceased to be
recorded and could not be reasonably included in this study.
Other key characteristics were either not recorded (socioeco-
nomic status, parity) or so poorly recorded they could not be
included as a variable in this study (ethnicity). The data is also
manually entered and relies upon accurate self-report from the
women consulting the pharmacist therefore the data accuracy is
likely to vary somewhat depending on how personally sensitive
the variable in question is. Finally, by only looking at pharma-
cies, emergency contraception provision from other service
hubs (general practice, accident and emergency departments,
sexual health clinics, and, more recently, online services) is not
recorded and therefore this study certainly represents an under-
estimate of the full need for emergency contraception of
women residing within the Shropshire Local Authority
boundary.
Some of the above findings substantiate previously pub-
lished studies examining emergency contraception provision
in differing populations.1,3,17 The age distribution and pattern
of repeat use of emergency contraception mirror that of general
practice populations seeking emergency contraception prior to
the availability of emergency contraception in pharmacies,
indicating these women may have changed service provider.18
This study confirms current beliefs around pharmacies provid-
ing much improved access, and therefore convenience, over
other settings from which emergency contraception can be
Figure 4. Consultation outcome, April 2016 to January 2019.
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sought.3,19 Systematic review evidence supports the finding
that young people utilize pharmacies for sexual and reproduc-
tive healthcare in large numbers as they find it accessible and
acceptable.20 Trends in consultation rationale and repeat atten-
dances have also changed very little over time, with Lloyd and
Gale noting similar patterns in their 2005 study examining
emergency contraception dispensing in a rural part of York-
shire.1 Many studies have previously examined views around
pharmacists providing extra services, including chlamydia
screening. Thomas et al found that pharmacists believe offering
chlamydia screening is an integral part of their job, but in order
to avoid offence they tend not to offer it to every eligible
women, rather they prefer to make judgements upon the neces-
sity.21 This undermines the opportunistic nature of the screen-
ing program and the finding is likely to be replicated in our
data.21
Work has already been undertaken investigating pharma-
cists’ and women’s views on extending pharmacy-based sexual
and reproductive healthcare, including provision of ongoing
hormonal contraception at the time of emergency contraception
access.22,23 These small pilot studies provide promising results
but require further refinement, particularly in a rural setting
where pharmacists often work alone and may not have capacity
to take on the level of work proposed. Economic analysis of
these projects in the context of changing public health funding
is also required to enable the case to be made for funding if they
are found to be effective and acceptable.
Conclusion
This study highlights the importance of providing a compre-
hensive emergency contraception service in pharmacies in a
rural location in England. It provides evidence for local and
national policy makers in sexual and reproductive healthcare to
support commissioning decisions and requests for further fund-
ing. It also suggests that investing in pharmacies, as a location
for sexual and reproductive healthcare may be widely accepted
as pharmacies are easily accessible, confidential, and women
are often directed to them from other healthcare providers.
Authors’ Note
EP designed the study, carried out data analysis and wrote the original
draft article. KJ supported the study design process and contributed
towards subsequent revisions of the draft article.
Acknowledgments
The authors would like to thank Ms Lesley Talbot and Ms Ali Cart-
wright from Shropshire Council’s Sexual Health Commissioning
Team for their help in accessing the data. Thanks also go to The
Caldicott Guardian within Shropshire Council for granting the authors
permission to study this data and publish any subsequent findings.
This work has been presented in preliminary format via poster
submission at The Society for Academic Primary Care Conference,
University of Exeter, July 3-5, 2019.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to
the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, author-
ship, and/or publication of this article.
ORCID iD
Emma Pearce, MPH https://orcid.org/0000-0001-7608-0033
References
1. Lloyd K, Gale E. Provision of emergency hormonal contraception
through community pharmacies in a rural area. J Fam Plan
Reprod Heal Care. 2005;31(4):297-300.
2. Thomas CM, Cameron S. Can we reduces costs and prevent more
unintended pregnancies? A cost of illness and cost-effectiveness
study comparing two methods of EHC. BMJ Open. 2013;3(12):
e003815.
3. Mantzourani E, Hodson K, Evans A, et al. A 5-year evaluation of
the emergency contraception enhanced community pharmacy ser-
vice provided in Wales. BMJ Sex Reprod Heal. 2019;45(4):
275-282.
4. The Faculty of Sexual and Reproductive Healthcare. FSRH Clin-
ical Guideline: Emergency Contraception. Faculty of Sexual and
Reproductive and Sexual Healthcare; 2017.
5. Cameron ST, Li HWR, Gemzell-Danielsson K. Current contro-
versies with oral emergency contraception. BJOG. 2017;124(13):
1948-1956.
6. Parsons J, Adams C, Aziz N, Holmes J, Jawad R, Whittlesea C.
Evaluation of a community pharmacy delivered oral contracep-
tion service. J Fam Plan Reprod Heal Care. 2013;39(2):97-101.
7. Bauer J, Muller R, Bruggmann D, Groneberg DA. Spatial Acces-
sibility of primary care in England: a cross-sectional study using a
Table 1. Comparison of Key Characteristics of Single Versus Repeat Consulters.
Characteristic Single attendance Repeat attendances
Number of women (% study population) 2778 (89.6%) 321 (10.4%)
Number of consultations (%) 2778 (79.4%) 721 (20.6%)
Consultations aged 16-20 (%) 1020 (36.7%) 429 (59.5%)
Percent unprotected sexual intercourse 52.2% 55.1%
Accepted copper intrauterine device referral (%) 2.7% 3.9%
Chlamydia screening population aged 13-25 (% total population) 1751 (63%) 597 (83%)
Percent screened for chlamydia (eligible population only) 4.7% 5%
6 Journal of Pharmacy Practice XX(X)
floating catchment area method. Health Serv Res. 2018;53(3):
1957-1978.
8. Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all
areas? An area-level analysis of accessibility to general practice
and community pharmacy services in England by urbanity and
social deprivation. BMJ Open. 2015;5(5):e007328.
9. Baxter S, Blank L, Guillaume L, Squires H, Payne N. Views of
contraceptive service delivery to young people in the UK: a sys-
tematic review and thematic synthesis. BMJ Sex Reprod Heal.
2011;37(2):71-84.
10. Garside R, Ayres R, Owne M, Pearson VA, Roizen J. Anonymity
and confidentiality: rural teenagers’ concerns when accessing sex-
ual health services. J Fam Plan Reprod Healthc. 2002;28(1):23-26.
11. Hawkins KE, Thompson L, Wilson P. Access to chlamydia test-
ing in remote and rural Scotland. Rural Remote Heal. 2016;16(1):
3588.
12. Caird L, Cameron ST, Hough T, Mackay L, Glasier A. Initiatives
to close the gap in inequalities in abortion provision in a remote
nd rural UK setting. J Fam Plan Reprod Heal Care. 2016;42(1):
68-70.
13. The Kings Fund. Written Submission to the Health and Social
Care Committee’s Sexual Health Inquiry [Internet]. London;
Published 2019. Updated September 16, 2020. Accessed April
10, 2019. https://www.kingsfund.org.uk/sites/default/files/2019-
06/Sexualhealthinquiry_proofed.pdf
14. Pinnacle Health Partnership LLP. PharmOutcomes [Internet].
Published 2019. Updated September 16, 2020. Accessed August
3, 2019. https://pharmoutcomes.org/pharmoutcomes/
15. Public Health England. NCSP: Programme overview [Internet].
Published 2017. Updated September 16, 2020. Accessed April 10,
2019. https://www.gov.uk/government/publications/ncsp-pro
gramme-overview
16. The Office for National Statistics. Estimates of the population for
the UK, England and Wales, Scotland and Northern Ireland [Inter-
net]. Published 2019. Updated September 16, 2020. Accessed




17. Shawe J, Ineichen B, Lawrenson R. Emergency contraception:
who are the users? J Fam Reprod Healthc. 2001;27(4):209-212.
18. Rowlands S, Devalia H, Lawrenson R, Logie J, Ineichen B.
Repeated use of hormonal emergency contraception by
younger women in the UK. BMJ Sex Reprod Heal. 2000;
26(3):138-142.
19. Black KL, Mercer CH, Kubba A, Wellings K. Provision of emer-
gency contraception: a pilot study comparing access through phar-
macies and clinical settings. Contraception. 2008;77(3):181-185.
20. Gonsalves L, Hindin MJ. Pharmacy provision of sexual and repro-
ductive health commodities to young people: a systematic litera-
ture review and synthesis of the evidence. Contraception. 2017;
95(4):339-363.
21. Thomas G, Humphris G, Ozakinci G, et al. A qualitative study of
pharmacists’ views on offering chlamydia screening to women
requesting Emergency Hormonal Contraception. Br J Obstet
Gynaecol. 2010;117(1):109-113.
22. Michie L, Cameron ST, Glasier A, Larke N, Muir A, Lorimer A.
Pharmacy-based interventions for initiating effective contracep-
tion following the use of emergency contraception: a pilot study.
Contraception. 2014;90(4):447-453.
23. Michie L, Cameron ST, Glasier A, Chen ZE, Milne D, Wilson S.
Provision of contraception after emergency contraception from
the pharmacy: evaluating the acceptability of pharmacy for pro-
viding sexual and reproductive health services. Public Health.
2016;135:97-103.
Pearce and Jolly 7
